Public procurement notice: Contract Award Notice
Published: 2019-07-19
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products
Estimated value: 15912988 GBP
Award criteria: The most economic tender

Technical requirements: This Framework Agreement is for the supply of cardiovascular and respiratory medicines to health boards across NHS Scotland.
The goods have been split into fourteen (14) categories, each of which is identified as a ‘Lot’. Full details of each lot is contained in Section II.2 of this notice.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to new public bodies (Joint Working) Scotland Act 2014.
Supply of diltiazem hydrochloride modified release capsules and tablets to NHS Scotland in a range of presentations. The authority intended to award each product line as a multi-supplier unranked Framework Agreement on a line by line basis to an envisaged maximum of 6 suppliers.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Verapamil Hydrochloride Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Nifedipine Modified Release Capsules and Tablets to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Branded and Branded Generic Inhalers to NHS Scotland in a range of presentations. The Authority intended to award each product line as a multi-supplier unranked framework agreement on a line by line basis to an envisaged maximum of 6 Suppliers.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
Supply of Epoprostenol 500mcg and 1.5mg powder and solvent (pH12) for solution for infusion vials to NHS Scotland. The Authority intended to award a multi-supplier unranked framework agreement for the Lot to an envisaged maximum of 6 Suppliers.
Access to contract pricing required by the designated Homecare company for supply to patients receiving treatment for Pulmonary Arterial Hypertension via the Homecare delivery contract.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014


Winner: Mercury Pharma Group
Award value: 15912988
Number of bids: 1